• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于芳基氟硫酸盐的赖氨酸共价泛凋亡蛋白(IAP)拮抗剂细胞效力。

Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy.

出版信息

J Med Chem. 2019 Oct 24;62(20):9188-9200. doi: 10.1021/acs.jmedchem.9b01108. Epub 2019 Oct 8.

DOI:10.1021/acs.jmedchem.9b01108
PMID:31550155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7580997/
Abstract

We have recently investigated the reactivity of aryl-fluorosulfates as warheads to form covalent adducts with Lys, Tyr, and His residues. However, the rate of reaction of aryl-fluorosulfates seemed relatively slow, putting into question their effectiveness to form covalent adducts in cell. Unlike the previously reported agents that targeted a relatively remote Lys residue with respect to the target's binding site, the current agents were designed to more directly juxtapose an aryl-fluorosulfate with a Lys residue that is located within the binding pocket of the BIR3 domain of X-linked inhibitor of apoptosis protein (XIAP). We found that such new agents can effectively and rapidly form a covalent adduct with XIAP-BIR3 in vitro and in cell, approaching the rate of reaction, cellular permeability, and stability that are similar to what attained by acrylamides when targeting Cys residues. Our studies further validate aryl-fluorosulfates as valuable Lys-targeting electrophiles, for the design of inhibitors of both enzymes and protein-protein interactions.

摘要

我们最近研究了芳基氟硫酸酯作为弹头与赖氨酸(Lys)、酪氨酸(Tyr)和组氨酸(His)残基形成共价加合物的反应性。然而,芳基氟硫酸酯的反应速率似乎相对较慢,这使得它们在细胞中形成共价加合物的有效性受到质疑。与之前报道的针对靶结合位点相对较远的赖氨酸残基的试剂不同,当前的试剂设计为更直接地将芳基氟硫酸酯与位于凋亡蛋白抑制因子(XIAP)的 BIR3 结构域结合口袋内的赖氨酸残基并置。我们发现,这些新型试剂可以有效地快速在体外和细胞内与 XIAP-BIR3 形成共价加合物,其反应速率、细胞通透性和稳定性与针对半胱氨酸残基的丙烯酰胺相似。我们的研究进一步验证了芳基氟硫酸酯作为有价值的赖氨酸靶向亲电试剂,可用于设计酶和蛋白质-蛋白质相互作用的抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/a2dfd3ce85a0/nihms-1636517-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/b082ffb97c68/nihms-1636517-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/b36fb9b18e03/nihms-1636517-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/bfb4161df5b8/nihms-1636517-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/c22e48532946/nihms-1636517-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/fa5b378e2c94/nihms-1636517-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/a2dfd3ce85a0/nihms-1636517-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/b082ffb97c68/nihms-1636517-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/b36fb9b18e03/nihms-1636517-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/bfb4161df5b8/nihms-1636517-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/c22e48532946/nihms-1636517-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/fa5b378e2c94/nihms-1636517-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7580997/a2dfd3ce85a0/nihms-1636517-f0012.jpg

相似文献

1
Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy.基于芳基氟硫酸盐的赖氨酸共价泛凋亡蛋白(IAP)拮抗剂细胞效力。
J Med Chem. 2019 Oct 24;62(20):9188-9200. doi: 10.1021/acs.jmedchem.9b01108. Epub 2019 Oct 8.
2
Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys-Covalent Antagonists of Protein-Protein Interactions.磺酰氟的稳定性和细胞通透性在设计赖氨酸半胱氨酸共价拮抗蛋白-蛋白相互作用中的作用。
ChemMedChem. 2020 Nov 18;15(22):2176-2184. doi: 10.1002/cmdc.202000355. Epub 2020 Oct 13.
3
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues.靶向赖氨酸、酪氨酸或组氨酸残基的蛋白质-蛋白质相互作用的共价抑制剂。
J Med Chem. 2019 Jun 13;62(11):5616-5627. doi: 10.1021/acs.jmedchem.9b00561. Epub 2019 May 29.
4
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach.基于热力学驱动方法设计高效的 pan-IAP 和 Lys-C 共价 XIAP 选择性抑制剂。
J Med Chem. 2018 Jul 26;61(14):6350-6363. doi: 10.1021/acs.jmedchem.8b00810. Epub 2018 Jul 9.
5
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein.赖氨酸共价拮抗剂的黑色素抑制剂的凋亡蛋白。
J Med Chem. 2021 Nov 11;64(21):16147-16158. doi: 10.1021/acs.jmedchem.1c01459. Epub 2021 Oct 27.
6
Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.一种强效、口服生物可利用的半胱天冬酶蛋白酶(caspase)-募集结构域(CARD)结合凋亡蛋白(IAP)拮抗剂的鉴定。
J Med Chem. 2023 Jun 22;66(12):8159-8169. doi: 10.1021/acs.jmedchem.3c00467. Epub 2023 Jun 1.
7
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.苯并二氮杂酮类作为 X 连锁凋亡抑制蛋白(XIAP)第二杆状病毒 IAP 重复(BIR2)结构域选择性抑制剂的优化。
J Med Chem. 2013 Oct 24;56(20):7788-803. doi: 10.1021/jm400732v. Epub 2013 Oct 7.
8
Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.基于结构的设计和 Smac 模拟物的分子特征分析,针对细胞 IAP 的选择性。
FEBS J. 2018 Sep;285(17):3286-3298. doi: 10.1111/febs.14616. Epub 2018 Aug 16.
9
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.苯并二氮杂卓酮和苯并恶唑二氮杂卓作为凋亡蛋白抑制剂(IAPs)的拮抗剂,对第二个杆状病毒 IAP 重复(BIR2)结构域具有选择性。
J Med Chem. 2013 Oct 24;56(20):7772-87. doi: 10.1021/jm400731m. Epub 2013 Oct 1.
10
Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.一种通过拮抗凋亡抑制蛋白使癌细胞对凋亡敏感的强效Smac模拟物的设计、合成及生物学活性
ACS Chem Biol. 2006 Sep 19;1(8):525-33. doi: 10.1021/cb600276q.

引用本文的文献

1
SuFEx-based antitubercular compound irreversibly inhibits Pks13.基于SuFEx的抗结核化合物可不可逆地抑制Pks13。
Nature. 2025 Jul 30. doi: 10.1038/s41586-025-09286-3.
2
Advances in sulfonyl exchange chemical biology: expanding druggable target space.磺酰基交换化学生物学的进展:拓展可成药靶点空间
Chem Sci. 2025 May 6;16(23):10119-10140. doi: 10.1039/d5sc02647d. eCollection 2025 Jun 11.
3
Proximity-induced SuFEx increases the potency of cytosolic nucleotidase inhibitors and reveals a rare example of covalently targeted histidine.

本文引用的文献

1
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues.靶向赖氨酸、酪氨酸或组氨酸残基的蛋白质-蛋白质相互作用的共价抑制剂。
J Med Chem. 2019 Jun 13;62(11):5616-5627. doi: 10.1021/acs.jmedchem.9b00561. Epub 2019 May 29.
2
Characterising covalent warhead reactivity.描述共价弹头的反应活性。
Bioorg Med Chem. 2019 May 15;27(10):2066-2074. doi: 10.1016/j.bmc.2019.04.002. Epub 2019 Apr 3.
3
Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors.
邻近诱导的硫氟交换反应增强了胞质核苷酸酶抑制剂的效力,并揭示了一个罕见的共价靶向组氨酸的例子。
RSC Chem Biol. 2025 Apr 23. doi: 10.1039/d5cb00005j.
4
A fragment-based electrophile-first approach to target histidine with aryl-fluorosulfates: application to hMcl-1.一种基于片段的亲电试剂优先靶向组氨酸的芳基氟硫酸盐方法:应用于人类髓细胞白血病-1蛋白
Res Sq. 2025 Mar 26:rs.3.rs-6214862. doi: 10.21203/rs.3.rs-6214862/v1.
5
Target Bioconjugation of Protein Through Chemical, Molecular Dynamics, and Artificial Intelligence Approaches.通过化学、分子动力学和人工智能方法实现蛋白质的靶向生物共轭
Metabolites. 2024 Dec 2;14(12):668. doi: 10.3390/metabo14120668.
6
Covalent Targeting of Histidine Residues with Aryl Fluorosulfates: Application to Mcl-1 BH3 Mimetics.芳基氟硫酸酯的组氨酸残基共价靶向:在 Mcl-1 BH3 模拟物中的应用。
J Med Chem. 2024 Nov 28;67(22):20214-20223. doi: 10.1021/acs.jmedchem.4c01541. Epub 2024 Nov 12.
7
Sulfur fluoride exchange.硫氟交换
Nat Rev Methods Primers. 2023;3. Epub 2023 Aug 3.
8
Histidine-Covalent Stapled Alpha-Helical Peptides Targeting hMcl-1.靶向 hMcl-1 的组氨酸共价键合的螺旋肽
J Med Chem. 2024 May 23;67(10):8172-8185. doi: 10.1021/acs.jmedchem.4c00277. Epub 2024 May 2.
9
A simple method for developing lysine targeted covalent protein reagents.一种用于开发赖氨酸靶向共价蛋白质试剂的简单方法。
Nat Commun. 2023 Dec 1;14(1):7933. doi: 10.1038/s41467-023-42632-5.
10
Covalent targeting of non-cysteine residues in PI4KIIIβ.磷脂酰肌醇4激酶IIIβ中非半胱氨酸残基的共价靶向
RSC Chem Biol. 2023 Oct 17;4(12):1111-1122. doi: 10.1039/d3cb00142c. eCollection 2023 Nov 29.
评估赖氨酸和半胱氨酸反应性以设计靶向共价激酶抑制剂。
J Am Chem Soc. 2019 Apr 24;141(16):6553-6560. doi: 10.1021/jacs.8b13248. Epub 2019 Apr 16.
4
Covalent binders in drug discovery.药物研发中的共价结合剂。
Prog Med Chem. 2019;58:1-62. doi: 10.1016/bs.pmch.2018.12.002. Epub 2019 Mar 11.
5
Covalent Inhibition in Drug Discovery.药物发现中的共价抑制。
ChemMedChem. 2019 May 6;14(9):889-906. doi: 10.1002/cmdc.201900107. Epub 2019 Mar 26.
6
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.凋亡抑制蛋白(IAP)拮抗剂在抗癌药物研发中的应用:现状与展望。
J Med Chem. 2019 Jun 27;62(12):5750-5772. doi: 10.1021/acs.jmedchem.8b01668. Epub 2019 Feb 1.
7
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.新兴与重现的靶向共价抑制剂弹头:在药物化学和化学生物学中的应用。
J Med Chem. 2019 Jun 27;62(12):5673-5724. doi: 10.1021/acs.jmedchem.8b01153. Epub 2019 Jan 25.
8
Covalent vs. Non-Covalent Inhibition: Tackling Drug Resistance in EGFR - A Thorough Dynamic Perspective.共价抑制与非共价抑制:从全面动态视角应对表皮生长因子受体(EGFR)的耐药性
Chem Biodivers. 2019 Mar;16(3):e1800518. doi: 10.1002/cbdv.201800518. Epub 2019 Feb 5.
9
Covalent Inhibition in Drug Discovery: Filling the Void in Literature.共价抑制在药物发现中的应用:填补文献空白。
Curr Top Med Chem. 2018;18(13):1135-1145. doi: 10.2174/1568026618666180731161438.
10
Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.基于结构的设计和 Smac 模拟物的分子特征分析,针对细胞 IAP 的选择性。
FEBS J. 2018 Sep;285(17):3286-3298. doi: 10.1111/febs.14616. Epub 2018 Aug 16.